Wyndham Hotels & Resorts (NYSE:WH) declared a dividend on Monday, May 21st, Fidelity reports. Stockholders of record on Friday, June 15th will be given a dividend of 0.25 per share on Friday, June 29th. The ex-dividend date is Thursday, June 14th.
Shares of NYSE WH traded down $0.86 during trading on Wednesday, hitting $59.66. 2,651,300 shares of the company were exchanged, compared to its average volume of 1,783,007. Wyndham Hotels & Resorts has a 12-month low of $57.29 and a 12-month high of $66.95.
WH has been the topic of several analyst reports. Wolfe Research initiated coverage on Wyndham Hotels & Resorts in a report on Friday, June 1st. They set a “market perform” rating on the stock. Oppenheimer initiated coverage on Wyndham Hotels & Resorts in a report on Monday, June 4th. They set an “outperform” rating and a $69.00 price target on the stock. Goldman Sachs Group initiated coverage on Wyndham Hotels & Resorts in a report on Monday, June 4th. They set a “buy” rating and a $82.00 price target on the stock. Stifel Nicolaus initiated coverage on Wyndham Hotels & Resorts in a report on Monday, June 4th. They set a “buy” rating and a $68.00 price target on the stock. Finally, JPMorgan Chase & Co. initiated coverage on Wyndham Hotels & Resorts in a report on Thursday, May 31st. They set an “overweight” rating and a $66.00 price target on the stock. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $73.00.
Top 10 Heal Care Stocks To Own Right Now: Snap-On Incorporated(SNA)
Advisors' Opinion:- [By Joseph Griffin]
Earnest Partners LLC decreased its position in Snap-on Incorporated (NYSE:SNA) by 0.6% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 982,944 shares of the company’s stock after selling 5,445 shares during the quarter. Snap-on makes up 1.4% of Earnest Partners LLC’s portfolio, making the stock its 13th biggest holding. Earnest Partners LLC’s holdings in Snap-on were worth $145,024,000 at the end of the most recent quarter.
- [By Dan Caplinger]
Thursday ended in the red for most major benchmarks on Wall Street, with the Dow trading down by triple digits at times before climbing back toward the close. After having bounced back sharply in recent days, stocks seemed to lose upward momentum, and interest rate fears returned to the market. The yield on the 10-year Treasury bond once again moved above the 2.9% mark, and shorter-term Treasurys had yields reach levels they haven't seen in years. Yet even though the overall market was ready to take a break, some companies still enjoyed good news that lifted their shares. Bank of New York Mellon (NYSE:BK), Snap-on (NYSE:SNA), and Rigel Pharmaceuticals (NASDAQ:RIGL) were among the best performers on the day. Here's why they did so well.
- [By Joseph Griffin]
Mountain Pacific Investment Advisers Inc. ID reduced its stake in Snap-on (NYSE:SNA) by 0.3% during the 1st quarter, HoldingsChannel.com reports. The firm owned 154,025 shares of the company’s stock after selling 440 shares during the quarter. Snap-on makes up approximately 2.3% of Mountain Pacific Investment Advisers Inc. ID’s holdings, making the stock its 14th biggest holding. Mountain Pacific Investment Advisers Inc. ID’s holdings in Snap-on were worth $22,725,000 at the end of the most recent reporting period.
- [By Logan Wallace]
American Century Companies Inc. reduced its position in Snap-on (NYSE:SNA) by 93.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 17,330 shares of the company’s stock after selling 253,734 shares during the quarter. American Century Companies Inc.’s holdings in Snap-on were worth $2,557,000 as of its most recent SEC filing.
- [By Shane Hupp]
Swiss National Bank lowered its position in shares of Snap-on (NYSE:SNA) by 13.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 183,800 shares of the company’s stock after selling 29,700 shares during the quarter. Swiss National Bank owned 0.32% of Snap-on worth $27,118,000 as of its most recent filing with the SEC.
Top 10 Heal Care Stocks To Own Right Now: eBay Inc.(EBAY)
Advisors' Opinion:- [By Motley Fool Staff]
Argersinger:�I've been to the website. What's interesting, listeners might not know this -- it was owned by eBay (NASDAQ:EBAY)�at one point, and then, eBay owned a partial stake in it. But for a long time, if you did eBay Latin America, it would send you right to�MercadoLibre. So, I looked at that for many years, comparing it to eBay, and seeing if there were changes and differences. But, no, personally, I've been to the website, but of course I have not ordered anything from it.
- [By Ethan Ryder]
State of Wisconsin Investment Board increased its holdings in eBay (NASDAQ:EBAY) by 5.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,187,584 shares of the e-commerce company’s stock after acquiring an additional 61,028 shares during the period. State of Wisconsin Investment Board owned about 0.12% of eBay worth $47,788,000 at the end of the most recent quarter.
- [By Anders Bylund, Leo Sun, and Demitrios Kalogeropoulos]
Demitri Kalogeropoulos (eBay): A key strength of Warren Buffett is his ability to pair a clear idea of what he doesn't know with the discipline to stay far away from these investments. Most financial opportunities go into what he calls his "too hard" pile that's packed with businesses whose valuations he can't forecast into the distant future. If cryptocurrencies fall into that category for you, consider eBay, a much easier-to-understand business.
Top 10 Heal Care Stocks To Own Right Now: Century Aluminum Company(CENX)
Advisors' Opinion:- [By ]
You can see why Century Aluminum (Nasdaq: CENX) commended the President for "acting swiftly and boldly to save the American aluminum industry." The company intends to ramp up operations at its smelter in Hawesville, Kentucky, putting 300 people back to work. In Illinois, US Steel (NYSE: X) is restarting a blast furnace that will employ at least 500 new workers.
- [By D.R. Barton, Jr.]
According to industry leaders, including Century Aluminum Co. (Nasdaq: CENX) CEO Michael Bless, many of those jobs will be in jeopardy with the new taxes. And then there's the reciprocal tariff reactions from other nations that would definitely hit the billions of dollars' worth of U.S. agricultural exports with further jobs in jeopardy.
- [By Matthew DiLallo]
Earlier this month,�the price of aluminum spiked after the U.S. government slapped sanctions on Rusal, the second-largest supplier of aluminum to the U.S. and Canada. That news sent the stocks of U.S. aluminum producers like Alcoa and Century Aluminum (NASDAQ:CENX) soaring on the belief that they'd profit from the higher prices that would likely result from the sanctions.
- [By Logan Wallace]
Century Aluminum (NASDAQ:CENX) was downgraded by research analysts at TheStreet from a “b-” rating to a “c” rating in a report released on Thursday.
Top 10 Heal Care Stocks To Own Right Now: Cray Inc(CRAY)
Advisors' Opinion:- [By Motley Fool Staff]
Gardner:�There's�a lot of biotech and some computer companies. We once visited the Cray Corporation (NASDAQ:CRAY), which was one of the early supercomputer companies.�Seymour Cray was one of the pioneers of supercomputing. If you look up Cray Computers, they were the supercomputers back in the 80s, when computers were a lot bigger than they are today, and�probably slower, but they were super back then. Anyway,�that was a Minneapolis company I once visited. Our dad used to take us, occasionally, on trips. We'd just drop by corporate headquarters and talk to an investor relations person. That was one of the times I did that. It�wasn't like I did it dozens of times. We did maybe five or six times. But�I'll always remember Cray Computer.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Cray (CRAY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 10 Heal Care Stocks To Own Right Now: American River Bankshares(AMRB)
Advisors' Opinion:- [By Ethan Ryder]
American River Bank (NASDAQ:AMRB) Director Kimberly Ann Box sold 2,900 shares of the business’s stock in a transaction on Thursday, May 3rd. The stock was sold at an average price of $15.64, for a total transaction of $45,356.00. Following the transaction, the director now directly owns 15,824 shares in the company, valued at $247,487.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
- [By Logan Wallace]
American River Bank (NASDAQ:AMRB) CEO David E. Ritchie, Jr. bought 2,250 shares of the stock in a transaction dated Monday, May 7th. The shares were acquired at an average price of $15.65 per share, for a total transaction of $35,212.50. Following the completion of the transaction, the chief executive officer now owns 20,987 shares of the company’s stock, valued at approximately $328,446.55. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.
Top 10 Heal Care Stocks To Own Right Now: Zumiez Inc.(ZUMZ)
Advisors' Opinion:- [By Garrett Baldwin] Goldman Sachs Group Inc. (NYSE: GS) chief economist Jan Hatzius has a message for the markets. Hatzius said in a research note on Monday that U.S. GDP has likely peaked. "The current pace is probably as good as it gets because we expect the impulse from financial conditions to gradually turn more negative," Hatzius said. The European Union slapped America with roughly $3.3 billion in tariffs on U.S. goods. The tariffs, which are in retaliation to the Trump administration's recent steel and aluminum tariffs on the EU, will go into effect in July. They specifically target products like cigarettes, whiskey, denim, and orange juice. Stocks to Watch Today: AVGO, AGN, GOOGL, TSLA Broadcom Ltd.�(Nasdaq: AVGO) leads a busy day of earnings reports. Wall Street anticipates the firm will report earnings per share of $4.77 on top of $5.00 billion in revenue. Uncertainty still remains on whether the company will be able to purchase industry rival Qualcomm Inc.�(Nasdaq: QCOM) in a deal that would be the largest technology merger in the history of the markets. Shares of Alphabet Inc. (Nasdaq: GOOGL) are under pressure due to more regulatory scrutiny by the European Union. Shares were off slightly this morning as investors digested a report from The Financial Times indicating the EU will hit the firm with a antitrust fine. Tesla Inc. (Nasdaq: TSLA) stock popped nearly 10% Wednesday, crushing short sellers of the stock. Investors betting against the stock lost a collective $1 billion on paper yesterday, according to S3 Partners. This week, founder Elon Musk won a battle to maintain his roles as both CEO and chair. He also provided a boost of optimism to TSLA stock over production expectations for the Model 3 vehicle. Allergan Inc. (NYSE: AGN) shares are up 2.4% thanks to its latest activist investor. Billionaire investor Carl Icahn purchased a small stake in the drug maker at a time when other activist investors are pushing for strategic changes by the company.
- [By Shane Hupp]
Zumiez (NASDAQ:ZUMZ) CEO Richard Miles Brooks sold 3,957 shares of Zumiez stock in a transaction dated Wednesday, June 6th. The shares were sold at an average price of $27.00, for a total transaction of $106,839.00. Following the completion of the sale, the chief executive officer now owns 3,709,067 shares in the company, valued at approximately $100,144,809. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
- [By Motley Fool Staff]
Zumiez (NASDAQ:ZUMZ) Q1 2018 Earnings Conference CallJun. 7, 2018 5:00 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
- [By Max Byerly]
Shares of Zumiez (NASDAQ:ZUMZ) reached a new 52-week high and low during trading on Tuesday . The company traded as low as $27.00 and last traded at $26.72, with a volume of 30728 shares traded. The stock had previously closed at $25.10.
Top 10 Heal Care Stocks To Own Right Now: Boston Properties, Inc.(BXP)
Advisors' Opinion:- [By Max Byerly]
Earnest Partners LLC raised its holdings in shares of Boston Properties, Inc. (NYSE:BXP) by 4.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 187,347 shares of the real estate investment trust’s stock after purchasing an additional 8,269 shares during the period. Earnest Partners LLC owned 0.12% of Boston Properties worth $23,085,000 as of its most recent SEC filing.
- [By ]
Selected examples: (BXP) , (DFS) , (HST) , (MA) , (TXN) , (USB) .
Inflation Is a Key RiskExecs were most worried about inflation, as they should be.
- [By Logan Wallace]
Boston Properties (NYSE:BXP) insider Bryan J. Koop sold 10,560 shares of the firm’s stock in a transaction on Friday, May 11th. The shares were sold at an average price of $124.27, for a total value of $1,312,291.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
- [By Stephan Byrd]
St. Johns Investment Management Company LLC reduced its position in Boston Properties (NYSE:BXP) by 9.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,745 shares of the real estate investment trust’s stock after selling 625 shares during the quarter. St. Johns Investment Management Company LLC’s holdings in Boston Properties were worth $708,000 at the end of the most recent reporting period.
- [By Logan Wallace]
Traders purchased shares of Boston Properties (NYSE:BXP) on weakness during trading hours on Friday. $96.18 million flowed into the stock on the tick-up and $15.73 million flowed out of the stock on the tick-down, for a money net flow of $80.45 million into the stock. Of all stocks tracked, Boston Properties had the 13th highest net in-flow for the day. Boston Properties traded down ($0.15) for the day and closed at $117.09
Top 10 Heal Care Stocks To Own Right Now: Standard Motor Products, Inc.(SMP)
Advisors' Opinion:- [By Stephan Byrd]
Liberum Capital reaffirmed their buy rating on shares of St. Modwen Properties (LON:SMP) in a research report released on Wednesday morning.
Several other research analysts have also weighed in on SMP. Peel Hunt reissued a buy rating on shares of St. Modwen Properties in a research report on Tuesday. JPMorgan Chase & Co. reissued an overweight rating and issued a GBX 475 ($6.32) price objective on shares of St. Modwen Properties in a research report on Wednesday, February 7th. Finally, Numis Securities reissued a buy rating and issued a GBX 488 ($6.50) price objective on shares of St. Modwen Properties in a research report on Wednesday, March 14th.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Standard Motor Products (SMP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Get a free copy of the Zacks research report on Standard Motor Products (SMP)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By ]
Through its bond-buying securities and markets program (SMP) and the agreement on net financial assets (ANFA), the European Central Bank and euro-area central banks hold some 12.8 billion euros in Greek bonds, the profits from which are redistributed to euro-area governments. These profits from bond holdings, which will amount to around 4 billion euros until 2022, have been promised to Greece in order to help it ease its debt burden. This sum will likely be split into annual disbursements and used as a carrot creditors can offer Greece over the next few years in order to ensure the country sticks to its reform commitments and fiscal path.
Top 10 Heal Care Stocks To Own Right Now: Ultragenyx Pharmaceutical Inc.(RARE)
Advisors' Opinion:- [By Joseph Griffin]
BidaskClub upgraded shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) from a hold rating to a buy rating in a report released on Monday.
A number of other brokerages have also recently weighed in on RARE. JPMorgan Chase restated an overweight rating and issued a $66.00 price objective (down from $68.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. Evercore ISI upgraded shares of Ultragenyx Pharmaceutical from an in-line rating to an outperform rating in a research note on Monday, January 22nd. Stifel Nicolaus restated a buy rating and issued a $74.00 price objective (down from $85.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, February 21st. ValuEngine upgraded shares of Ultragenyx Pharmaceutical from a sell rating to a hold rating in a research note on Wednesday, April 4th. Finally, Wedbush reiterated a positive rating and set a $71.00 target price (up from $64.00) on shares of Ultragenyx Pharmaceutical in a research note on Wednesday, April 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company. Ultragenyx Pharmaceutical presently has a consensus rating of Buy and an average price target of $69.76.
- [By Shane Hupp]
Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) Director Matthew K. Fust sold 6,319 shares of the business’s stock in a transaction that occurred on Wednesday, May 30th. The shares were sold at an average price of $72.00, for a total value of $454,968.00. Following the transaction, the director now owns 8,750 shares of the company’s stock, valued at $630,000. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
- [By Chris Lange]
Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.
- [By Shane Hupp]
These are some of the media headlines that may have effected Accern’s scoring:
Get Ultragenyx Pharmaceutical alerts: Burosumab Improves Outcomes in Children with XLH in Phase 2 Trial (raredr.com) RARE Stock Is on the Verge of Breaking Out Toward Higher Prices (profitconfidential.com) Burosumab may benefit children with X-linked hypophosphatemia (medicalxpress.com) A Look Inside the Quant Data For Ultragenyx Pharmaceutical Inc. (NasdaqGS:RARE) (parkcitycaller.com) Ultragenyx Pharmaceutical Inc. (RARE)- Stock in the Trader’s Radar (nasdaqfortune.com)A number of research firms have recently weighed in on RARE. ValuEngine raised Ultragenyx Pharmaceutical from a “hold” rating to a “buy” rating in a report on Saturday. BidaskClub raised Ultragenyx Pharmaceutical from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 19th. Barclays raised Ultragenyx Pharmaceutical from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $62.00 to $74.00 in a report on Friday, May 11th. Goldman Sachs Group began coverage on Ultragenyx Pharmaceutical in a report on Thursday, May 10th. They set a “neutral” rating and a $63.00 target price for the company. Finally, Zacks Investment Research downgraded Ultragenyx Pharmaceutical from a “hold” rating to a “sell” rating in a report on Tuesday, January 30th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $70.06.
- [By Todd Campbell]
A Genentech alumnus, Conner was previously vice president of clinical science at Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biotech that has successfully developed therapies for rare and ultrarare diseases. Prior to that, he was senior medical director at BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), another biotech company that's successfully developed drugs for rare diseases.
Top 10 Heal Care Stocks To Own Right Now: Midatech Pharma PLC(MTP)
Advisors' Opinion:- [By Logan Wallace]
News articles about Midatech Pharma (NASDAQ:MTP) have trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Midatech Pharma earned a coverage optimism score of 0.04 on Accern’s scale. Accern also gave press coverage about the company an impact score of 47.6134155747452 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
- [By Money Morning Staff Reports]
But before we show you our pick, here are the top 10 penny stocks to watch this week…
Penny Stocks Current Share Price (as of Jan. 5) Jan. 2-5 Gain (as of Jan. 5) My Size Inc. (Nasdaq: MYSZ) $1.66 152.28% Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.47 89.52% DelMar Pharmaceuticals Inc. (Nasdaq: DMPI) $1.675 58.02% CAS Medical Systems Inc. (Nasdaq: CASM) $1.09 55.71% China HGS Real Estate Inc. (Nasdaq: HGSH) $1.83 47.58% Aethlon Medical Inc. (Nasdaq: AEMD) $1.56 43.12% Midatech Pharma Plc. (Nasdaq: MTP) $1.23 43.01% Comstock Holding Cos. Inc. (Nasdaq: CHCI) $1.87 36.5% Cenveo Inc. (Nasdaq: CVO) $1.20 31.82% EV Energy Partners LP (Nasdaq: EVEP) $0.6844 31.62%
FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it's completely free…
No comments:
Post a Comment